These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 16046046

  • 1. A new approach to preventing relapse in opiate addicts: a psychometric evaluation.
    Grüsser SM, Thalemann CN, Platz W, Gölz J, Partecke G.
    Biol Psychol; 2006 Mar; 71(3):231-5. PubMed ID: 16046046
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy.
    Chen TJ, Blum K, Payte JT, Schoolfield J, Hopper D, Stanford M, Braverman ER.
    Med Hypotheses; 2004 Mar; 63(3):538-48. PubMed ID: 15288384
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Is premature termination of opiate detoxification due to intensive withdrawal or craving?].
    Scherbaum N, Heppekausen K, Rist F.
    Fortschr Neurol Psychiatr; 2004 Jan; 72(1):14-20. PubMed ID: 14745685
    [Abstract] [Full Text] [Related]

  • 9. Maintenance treatment with depot opioid antagonists in subcutaneous implants: an alternative in the treatment of opioid dependence.
    Carreño JE, Alvarez CE, Narciso GI, Bascarán MT, Díaz M, Bobes J.
    Addict Biol; 2003 Dec; 8(4):429-38. PubMed ID: 14690879
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.
    Gerra G, Zaimovic A, Rustichelli P, Fontanesi B, Zambelli U, Timpano M, Bocchi C, Delsignore R.
    J Subst Abuse Treat; 2000 Mar; 18(2):185-91. PubMed ID: 10716102
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence.
    Kakko J, von Wachenfeldt J, Svanborg KD, Lidström J, Barr CS, Heilig M.
    Biol Psychiatry; 2008 Jan 15; 63(2):172-7. PubMed ID: 17850768
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly].
    Blennow G, Fergusson A, Medvedeo A.
    Lakartidningen; 2000 Apr 12; 97(15):1830-3. PubMed ID: 10815411
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-acting depot formulations of naltrexone for heroin dependence: a review.
    Krupitsky EM, Blokhina EA.
    Curr Opin Psychiatry; 2010 May 12; 23(3):210-4. PubMed ID: 20224403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.